NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.
复制标题

DOI:
10.3389/fimmu.2016.00607
复制
发表时间:
2016
影响因子:
7.3
通讯作者:
Blish CA
Blish CA
中科院分区:
医学2区
文献类型:
--
作者:
Hatton O;Strauss-Albee DM;Zhao NQ;Haggadone MD;Pelpola JS;Krams SM;Martinez OM;Blish CA

文献摘要

参考文献

被引文献

相似文献

爱泼斯坦 - 巴尔病毒(EBV)是一种人类γ - 疱疹病毒,它在宿主B细胞中建立潜伏感染并终身存在,同时与宿主免疫反应达到平衡。然而,当免疫系统因免疫抑制或免疫缺陷而受到干扰时,这些潜伏感染的B细胞会引发侵袭性B细胞淋巴瘤。自然杀伤(NK)细胞被认为在对病毒感染的早期免疫反应中至关重要,但其在控制感染B细胞扩增方面的作用尚不清楚。在此,我们报道来自健康人类供体的NK细胞对携带潜伏EBV的自体B淋巴母细胞系(LCLs)的杀伤作用相较于原代B细胞有所增强。NK细胞与自体EBV + LCL共培养可鉴定出一个产生干扰素γ并动员细胞毒性颗粒蛋白CD107a的NK细胞群。多参数流式细胞术和布尔分析显示,这些功能性细胞中NK细胞受体NKG2A的表达富集。此外,NKG2A + NK细胞比NKG2A - NK细胞更有效地裂解自体LCL。更具体地说,NKG2A + 2B4 + CD16 - CD57 - NKG2C - NKG2D +细胞构成了对潜伏感染的自体EBV + B细胞作出反应的主要NK细胞群。因此,一部分NK细胞识别和清除自体EBV感染的转化细胞的能力增强,为利用这部分细胞治疗EBV +恶性肿瘤奠定了基础。
Epstein–Barr virus (EBV) is a human γ-herpesvirus that establishes latency and lifelong infection in host B cells while achieving a balance with the host immune response. When the immune system is perturbed through immunosuppression or immunodeficiency, however, these latently infected B cells can give rise to aggressive B cell lymphomas. Natural killer (NK) cells are regarded as critical in the early immune response to viral infection, but their role in controlling expansion of infected B cells is not understood. Here, we report that NK cells from healthy human donors display increased killing of autologous B lymphoblastoid cell lines (LCLs) harboring latent EBV compared to primary B cells. Coculture of NK cells with autologous EBV+ LCL identifies an NK cell population that produces IFNγ and mobilizes the cytotoxic granule protein CD107a. Multi-parameter flow cytometry and Boolean analysis reveal that these functional cells are enriched for expression of the NK cell receptor NKG2A. Further, NKG2A+ NK cells more efficiently lyse autologous LCL than do NKG2A− NK cells. More specifically, NKG2A+2B4+CD16−CD57−NKG2C−NKG2D+ cells constitute the predominant NK cell population that responds to latently infected autologous EBV+ B cells. Thus, a subset of NK cells is enhanced for the ability to recognize and eliminate autologous, EBV-infected transformed cells, laying the groundwork for harnessing this subset for therapeutic use in EBV+ malignancies.
DOI: 10.4049/jimmunol.1303211
发表时间: 2014-05-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Hendricks DW;Balfour HH Jr;Dunmire SK;Schmeling DO;Hogquist KA;Lanier LL
通讯作者: Lanier LL
DOI: 10.1126/scitranslmed.3006702
发表时间: 2013-10-23
影响因子: 17.1
作者:
Horowitz A;Strauss-Albee DM;Leipold M;Kubo J;Nemat-Gorgani N;Dogan OC;Dekker CL;Mackey S;Maecker H;Swan GE;Davis MM;Norman PJ;Guethlein LA;Desai M;Parham P;Blish CA
通讯作者: Blish CA
DOI: 10.1182/blood-2014-01-553024
发表时间: 2014-10-16
期刊: BLOOD
影响因子: 20.3
作者:
Azzi, Tarik;Luenemann, Anna;Nadal, David
通讯作者: Nadal, David
DOI: 10.1182/blood-2004-05-2058
发表时间: 2004-12-01
期刊: BLOOD
影响因子: 20.3
作者:
Gumá, M;Angulo, A;López-Botet, M
通讯作者: López-Botet, M
DOI: 10.1182/blood-2013-11-538686
发表时间: 2014-04-03
期刊: BLOOD
影响因子: 20.3
作者:
Li, Feng-Yen;Chaigne-Delalande, Benjamin;Lenardo, Michael J.
通讯作者: Lenardo, Michael J.